USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
C2N DIAGNOSTICS, LLC
Address:
4041 FOREST PARK AVE
SAINT LOUIS, MO 63108-3213
EIN:
126142138
DUNS:
828289210
Number of Employees:
10
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $295,025.00 2
SBIR Phase II $814,440.00 1

Award List:

Measuring metabolism of C-terminal fragments of amyloid beta in the human central

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$133,098.00
Agency:
HHS
Principal Investigator:
Tim West
Abstract:
DESCRIPTION (provided by applicant): This grant will seek to develop a methodology that will allow us to test whether a promising new class of drugs for Alzheimer's disease is having the desired effect in the human brain. This methodology will allow pharma ceutical companies to make informed… More

Measuring metabolism of C-terminal fragments of amyloid beta in the human central

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$814,440.00
Agency:
HHS
Principal Investigator:
Tim West – 314-633-1886
Abstract:
DESCRIPTION (provided by applicant): This grant will seek to develop a methodology that will allow us to test whether a promising new class of drugs for Alzheimer's disease is having the desired effect in the human brain. This methodology will allow pharmaceutical companies to make informed… More

Development of novel assays for measuring concentration and metabolism of Tau in

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$161,927.00
Agency:
HHS
Principal Investigator:
Tim West – 314-633-1886
Abstract:
DESCRIPTION (provided by applicant): Recently, Drs. Randall Bateman and David Holtzman at the Washington University School of Medicine developed a novel stable isotope labeling kinetics (SILK) methodology for measuring the metabolism of amyloid beta (AB) in the human central nervous system (CNS).… More